Simulations Plus, Inc. $SLP Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC cut its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 32.3% in the 3rd quarter, Holdings Channel reports. The firm owned 66,086 shares of the technology company’s stock after selling 31,549 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Simulations Plus were worth $996,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in SLP. First Light Asset Management LLC bought a new stake in shares of Simulations Plus in the 2nd quarter worth approximately $6,232,000. Stephens Investment Management Group LLC acquired a new stake in Simulations Plus in the second quarter worth $4,687,000. Ameriprise Financial Inc. increased its position in Simulations Plus by 25.3% in the second quarter. Ameriprise Financial Inc. now owns 875,447 shares of the technology company’s stock worth $15,277,000 after buying an additional 176,747 shares during the period. Marshall Wace LLP lifted its stake in Simulations Plus by 435.9% in the second quarter. Marshall Wace LLP now owns 133,278 shares of the technology company’s stock valued at $2,326,000 after buying an additional 108,407 shares during the last quarter. Finally, Wellington Management Group LLP bought a new stake in Simulations Plus in the first quarter valued at $2,458,000. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Down 2.2%

Shares of SLP opened at $18.76 on Friday. The firm has a market capitalization of $378.01 million, a PE ratio of -5.83 and a beta of 1.16. The firm has a 50-day moving average price of $18.00 and a 200 day moving average price of $16.27. Simulations Plus, Inc. has a 52-week low of $12.39 and a 52-week high of $37.67.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Monday, December 1st. The technology company reported $0.10 EPS for the quarter, hitting analysts’ consensus estimates of $0.10. The company had revenue of $17.46 million for the quarter, compared to the consensus estimate of $17.41 million. Simulations Plus had a negative net margin of 81.74% and a positive return on equity of 13.27%. During the same period in the previous year, the firm earned $0.06 EPS. On average, equities analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Simulations Plus in a research report on Wednesday, October 8th. BTIG Research lowered shares of Simulations Plus from a “buy” rating to a “neutral” rating in a research note on Thursday, December 18th. Zacks Research upgraded shares of Simulations Plus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 28th. KeyCorp restated a “sector weight” rating on shares of Simulations Plus in a research note on Wednesday, October 29th. Finally, TD Cowen started coverage on Simulations Plus in a report on Tuesday, September 30th. They set a “hold” rating and a $16.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $24.40.

Simulations Plus Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.